Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer
R Wang, Z Liu, Z Fan, H Zhan - Cancer Letters, 2023 - Elsevier
Effector, memory and exhaustion are three phenotypes of CD8+ T cell. In tumor
microenvironment (TME), metabolism dysfunction of the three should take the blame for …
microenvironment (TME), metabolism dysfunction of the three should take the blame for …
Neutrophil extracellular traps in cancer therapy resistance
MH Shahzad, L Feng, X Su, A Brassard… - Cancers, 2022 - mdpi.com
Simple Summary Neutrophils are a type of white blood cell that also play a role in cancer.
They have been shown to influence various aspects of the disease, including resistance to …
They have been shown to influence various aspects of the disease, including resistance to …
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) expression has been
a trending topic in recent years due to its differential expression in a wide range of …
a trending topic in recent years due to its differential expression in a wide range of …
Immunotherapy approaches in HPV-associated head and neck cancer
R Julian, M Savani, JE Bauman - Cancers, 2021 - mdpi.com
Simple Summary Human papillomavirus (HPV)-positive head and neck squamous cell
carcinoma (HNSCC) represents a distinct entity with molecular, pathological, and clinical …
carcinoma (HNSCC) represents a distinct entity with molecular, pathological, and clinical …
Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo …
A Rühle, J Todorovic, SSK Spohn, E Gkika, C Becker… - Radiation …, 2022 - Springer
Background and purpose Tumor-infiltrating lymphocytes (TILs) are associated with
locoregional control (LRC) in head-and-neck squamous cell carcinoma (HNSCC) patients …
locoregional control (LRC) in head-and-neck squamous cell carcinoma (HNSCC) patients …
Therapeutic strategies for gastric cancer targeting immune cells: Future directions
Y Zhao, Y Bai, M Shen, Y Li - Frontiers in Immunology, 2022 - frontiersin.org
Gastric cancer (GC) is a malignancy with a high incidence and mortality, and the emergence
of immunotherapy has brought survival benefits to GC patients. Compared with traditional …
of immunotherapy has brought survival benefits to GC patients. Compared with traditional …
TIM3/CEACAM1 pathway involves in myeloid‐derived suppressor cells induced CD8+ T cells exhaustion and bone marrow inflammatory microenvironment in …
S Yu, X Ren, F Meng, X Guo, J Tao, W Zhang… - …, 2023 - Wiley Online Library
Myeloid‐derived suppressor cells (MDSC) induced cellular immune deficiency and bone
marrow inflammatory microenvironment play an important role in the pathogenesis and …
marrow inflammatory microenvironment play an important role in the pathogenesis and …
The role of different immunocompetent cell populations in the pathogenesis of head and neck cancer—regulatory mechanisms of pro-and anti-cancer activity and their …
K Starska-Kowarska - Cancers, 2023 - mdpi.com
Simple Summary According to the latest GLOBOCAN data, head and neck squamous cell
carcinoma (HNSCC) represents the sixth most prevalent human malignancy. Recent studies …
carcinoma (HNSCC) represents the sixth most prevalent human malignancy. Recent studies …
[HTML][HTML] The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers
Head and neck cancer (HNC) is the sixth most common cancer type, accounting for
approximately 277,597 deaths worldwide. Recently, the Food and Drug Administration …
approximately 277,597 deaths worldwide. Recently, the Food and Drug Administration …
Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers
A Meci, N Goyal, G Slonimsky - Cancers, 2024 - mdpi.com
Simple Summary The programmed death-1 receptor monoclonal antibody treatments
pembrolizumab and nivolumab have been successful in the treatment of recurrent or …
pembrolizumab and nivolumab have been successful in the treatment of recurrent or …